Cerliponase-Alfa-For-Neuronal-Ceroid-Lipofuscinosis-Type-2-Cln2-Disease Manufacturers, Suppliers & Companies
1 companies found
-
Manufacturerbased in San Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
Brineura - Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 CLN2 Disease
The first approved treatment for any form of Batten disease. Brineura (cerliponase alfa) is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you